Digitisation | August 16, 2023
Cipla launches knowledge sharing platform ‘Ciplamed 2.0’
CiplaMed 2.0 leverages advanced analytics and automation
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Subscribe To Our Newsletter & Stay Updated
